- Citations, last 5 years
- 39.3k
- Works, last 5 years
- 2 927
- h-index
- 429
- Scientists listed
- 0
- Grants since 2016
- 33
Grants received
2026 · research · Enkeltsatsninger
Feasibility Assessment of Point-of-Care Testing (POCT) in Long-Term Care Facilities in Denmark
Statens Serum Institut · funded by Novo Nordisk Fonden
2025 · research · IKAA
Gavi, The Vaccine Alliance
Mikkel Lyndrup · Statens Serum Institut · funded by European and Developing Countries Clinical Trials Partnership
2025 · research · NNF Sustain Programme Part 1
Danish National Birth Cohort
Bartlomiej Wilkowski · Statens Serum Institut · funded by Novo Nordisk Fonden
2025 · research · Grants for access to the Gefion AI Supercomputer
Interpreting Single-Cell Transcriptomics in Infectious Disease Immunology by Context-Aware AI Agents
Tu Hu · Statens Serum Institut · funded by Novo Nordisk Fonden
2025–2027 · research · Nordic networking activities to support knowledge development on the post-COVID…
Building Nordic Excellence in Post-COVID Research: A Registry-Based Workshop Series
Anders Hviid · Statens Serum Institut · funded by NordForsk
2025–2030 · research · R01
Dissecting the role of vaccine-promoted Th17 cells in protective immunity against tuberculosis
Rasmus Skaarup Mortensen · Statens Serum Institut · funded by National Institutes of Health
2024 · research · Pioneer Innovator
mRNA vaccine delivery platform that can be stockpiled for pandemic preparedness
Gabriel Pedersen · Statens Serum Institut · funded by Novo Nordisk Fonden
2024 · research · Research Infrastructure Programme
Enhancing the Danish Biobank Register (DBR) for Biomedical Research Advancement
Bartlomiej Wilkowski · Statens Serum Institut · funded by Novo Nordisk Fonden
2024–2026 · research · Global Health
Statens Serum Institut - to support the efforts to identify vaccine and mAbs candidates to prevent malaria infection in the world's poorest populations.
Statens Serum Institut · funded by Bill and Melinda Gates Foundation
2023–2025 · research · Global Health
Statens Serum Institut - to develop and execute a communications strategy for a recently completed TB vaccine trial, in the interests of rapid and transparent communication...
Statens Serum Institut · funded by Bill and Melinda Gates Foundation
2023 · research · Start Package Grants
Start Package Grant for Senior Researcher Henrik Svanström
Statens Serum Institut · funded by Novo Nordisk Fonden
2022–2026 · research · HORIZON - HORIZON-RIA
Respiratory Host-Pathogen Interaction
Statens Serum Institut · funded by European Commission
2022–2027 · research · Global Health
Statens Serum Institut - to support the First in Human trial of a promising, novel tuberculosis vaccine candidate
Statens Serum Institut · funded by Bill and Melinda Gates Foundation
2021 · research · Pioneer Innovator
Counteracting erroneous autoimmunity through vaccination - proof-of-concept for the CAF®16 vaccine adjuvant
Dennis Christensen · Statens Serum Institut · funded by Novo Nordisk Fonden
2021 · research · Conferences, Symposia and Workshops
Innovative approaches in large-scale research infrastructures
Lasse Boding · Statens Serum Institut · funded by Novo Nordisk Fonden
2021 · research · Research in long-term health consequences of COVID-19 illness
The long-term consequences of COVID-19 in patients with immune-mediated inflammatory diseases: nationwide Danish cohort studies
Tine Jess · Statens Serum Institut · funded by Novo Nordisk Fonden
2020 · research · Societal Responses to and Preparedness for Emerging Viral Infections – 2020 research programme
Monitoring of infections and infectious diseases
Statens Serum Institut · funded by Novo Nordisk Fonden
2020 · grant · Research Infrastructure
Mapping the genetic variations behind exercise intolerance and serious muscle damage
Mads Melbye · Statens Serum Institut · funded by Carlsbergfondet
2020 · research · Enkeltsatsninger
Establishment of a national COVID-19 test centre
Statens Serum Institut · funded by Novo Nordisk Fonden
2020–2026 · research · Global Health
Statens Serum Institut - to support phenotypic characterization of Klebsiella spp. and E. coli strains
Statens Serum Institut · funded by Bill and Melinda Gates Foundation
2020 · research · Støtte af projekter der søger at afbøde de sundhedsmæssige konsekvenser af coronavirus (COVID-19) epidemien i Danmark
Akut national forskningsinfrastruktur med blodprøver til COVID-19
Statens Serum Institut · funded by Novo Nordisk Fonden
2019 · grant · Internationalisation Fellowships
Comparative transcriptomics of the widespread Mycena mushrooms: What genomic features makes saprotrophs turn into opportunistic biotrophs and symbionts?
Christoffer Bugge Harder · Statens Serum Institut · funded by Carlsbergfondet
2019 · research · Hallas-Møller Ascending Investigator
Lifelong and transgenerational cardiovascular and renal consequences of preeclampsia
Heather A. Boyd · Statens Serum Institut · funded by Novo Nordisk Fonden
2019–2021 · research · Global Health
Statens Serum Institut - to supply key reagents for the development of novel prophylactics for malaria
Statens Serum Institut · funded by Bill and Melinda Gates Foundation
2019 · research · Skolarstipendier
Comparison of influenza-attributable mortality estimates using cause-specific and all-cause mortality data
Tyra Grove Krause · Statens Serum Institut · funded by Novo Nordisk Fonden
2018 · grant · Internationalisation Fellowships
Comparative transcriptomics of the widespread Mycena mushrooms: What genomic features makes saprotrophs turn into opportunistic biotrophs and symbionts?
Christoffer Bugge Harder · Statens Serum Institut · funded by Carlsbergfondet
2017–2022 · research · R01
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity
Rasmus Skaarup Mortensen · Statens Serum Institut · funded by National Institutes of Health
2017–2023 · research · R01
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity
Rasmus Skaarup Mortensen · Statens Serum Institut · funded by National Institutes of Health
2017–2024 · research · RIA
POR TB consortium; Phase 2 trial to determine efficacy of the multistage vaccine H56:IC31 for Prevention Of Recurrent TB disease
Rasmus Mortensen · Statens Serum Institut · funded by European and Developing Countries Clinical Trials Partnership
2017–2022 · research · R01
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity
Peter Lawaetz Andersen · Statens Serum Institut · funded by National Institutes of Health
2017–2022 · research · H2020 - RIA
Developing a Chlamydia Trachomatis vaccine
Statens Serum Institut · funded by European Commission
2017–2022 · research · R01
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity
Rasmus Skaarup Mortensen · Statens Serum Institut · funded by National Institutes of Health
2017–2022 · research · R01
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity
Peter Lawaetz Andersen · Statens Serum Institut · funded by National Institutes of Health